The Raise Report
New funds with capital to deploy #007
Since we started releasing this data we have covered over 514 funds that have raised over $183b of fresh capital to deploy. Money does not seem to be an issue, getting out of those investors is, but why is that?
💸 New Funds Looking to Give You Cash
🚀 $5.57B Across 15 New Investment Vehicles
A fresh wave of venture capital is committing approximately $5.57B through 15 distinct vehicles, targeting European mid-market growth, AI innovation, sports technology and pharmaceutical breakthroughs. These investments are reshaping the global startup ecosystem by fuelling high-impact sectors and innovative scaling opportunities.
Where the Money is Going
🌍 Geography at a Glance
Europe (59% of capital) – Dominating the landscape by targeting established mid-market companies through directly negotiated, large-scale investments.
USA (32% of capital) – Driving diverse, early-stage bets across health tech, cybersecurity, sports technology and consumer experiences.
China (5% of capital) – Fueling clinical-stage pharmaceutical and biotech innovation, accelerating the move from R&D to commercialisation.
Rest of the World (approx. 3% of capital) – Encompassing regions such as Australia, the UK and other global hotspots, with a spread of strategies from university-led innovation to advanced cybersecurity and sustainable technology plays.
🎯 Sector Priorities
Investment trends reveal a strategic rebalancing:
Diversified Venture Growth (58% of funds by $) – A broad portfolio approach investing in established ventures across multiple industries, reflecting a pragmatic, market-agnostic stance.
Artificial Intelligence & Digital Technology (18% of funds by $) – Driving next-generation innovation and market disruption through early-stage technological breakthroughs.
Sports & Entertainment Technology (15% of funds by $) – Transforming live experiences and media engagement, propelling digital and event-based platforms to new heights.
Emerging Plays in Healthcare & Pharmaceutical Innovation (5% of funds by $) – Advancing early-stage medical and clinical breakthroughs to improve patient outcomes.
Other Sectors (4% of funds by $) – Covering specialised investments in cybersecurity and clean energy, underscoring targeted niche opportunities.
🚀 Investment Stages
Funding allocation is distinctly split:
Early Stage (20% of funds) – Backing pre-seed to Series A companies in technology, health and digital sectors, igniting the spark of innovation.
Growth Stage (80% of funds) – Scaling ventures through Series B-D rounds, supporting companies poised for significant market expansion.
What This Means for Founders
The data reveals Europe as the leading hub for diversified venture growth, while artificial intelligence and sports technology secure significant backing. For founders, particularly those in early-stage innovation, aligning fundraising strategies with these trends can be key. Emphasising demonstrable market traction, robust growth plans and sector-specific differentiation will help capitalise on this robust, growth-stage momentum across global markets.
Fusion42's Global Super Accelerator (GSA) is not your typical accelerator—it’s a 10‑week execution co‐pilot engineered to drive real progress for founders. Every session, tool, and system is designed for immediate application—no fluff, just hard results.
Startup Playbook: Organise your essentials.
Go-To-Market Strategy: Focus on securing customer traction.
Fundraising Plan: Get investor-ready.
AI Roadmap: Seamlessly integrate AI across your organisation.
Relentless execution is the key: build something people want to pay for and investors want to fund. Join 250 founders, engage with 6 expert panels, attend 30 masterclasses, and participate in 8 live build workshops. Plus, practise your pitch at PITCH KUNG FU for a chance to pitch in front of over 100 investors—from Angels to VCs, at our FUSED pitch event.
All fund details below👇
If you have not joined the Fusion42 Community on Telegram —
it is probably time to do so.
For the ❤️ of Startups